Search

Your search keyword '"Altena, Anne M."' showing total 204 results

Search Constraints

Start Over You searched for: Author "Altena, Anne M." Remove constraint Author: "Altena, Anne M." Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
204 results on '"Altena, Anne M."'

Search Results

1. Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis

2. Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis

6. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

7. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.

8. Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review.

9. Common variants at 19p13 are associated with susceptibility to ovarian cancer (vol 42, pg 880, 2010)

10. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer.

11. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk

12. Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.

13. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.

14. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA

16. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

17. Polymorphisms in Stromal Genes and Susceptibility to Serous Epithelial Ovarian Cancer: A Report from the Ovarian Cancer Association Consortium

18. Common variants at 19p13 are associated with susceptibility to ovarian cancer.

20. Establishment of the Dutch Nationwide, Interdisciplinary Infrastructure and Biobank for Fundamental and Translational Ovarian Cancer Research:Archipelago of Ovarian Cancer Research (AOCR)

21. Establishment of the Dutch Nationwide, Interdisciplinary Infrastructure and Biobank for Fundamental and Translational Ovarian Cancer Research: Archipelago of Ovarian Cancer Research

22. Contraceptives and cancer risks in BRCA1/2 pathogenic variant carriers: a systematic review and meta-analysis.

24. Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer

26. Establishment of the Dutch nationwide, interdisciplinary infrastructure and biobank for fundamental and translational ovarian cancer research: Archipelago of Ovarian Cancer Research (AOCR)

27. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case–control studies

28. Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer

30. Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci

31. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case–control studies

32. Development of a decision aid for primary treatment of patients with advanced-stage ovarian cancer

33. Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0

36. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies

37. Abstract A044: A precision medicine platform to predict the clinical response to chemo- and immunotherapy for epithelial ovarian cancer

38. Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition.

39. Oncologic outcomes after splenectomy during initial cytoreductive surgery in advanced epithelial ovarian cancer: a nationwide population‐based cohort study.

42. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

43. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

44. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

45. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.

46. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

47. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

48. Genome-wide significant risk associations for mucinous ovarian carcinoma (vol 47, pg 888, 2015)

49. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

50. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC)

Catalog

Books, media, physical & digital resources